Get the free CONTINUING REVIEW FORM

Research Ethics Review Committee (WHO ERC) 20, AVENUE APIA CH1211 GENEVA 27 SWITZERLAND HTTP://INTRANET.WHO.INT/HOMES/RPC/ERC HTTP://WWW.WHO.INT/RPC/RESEARCH_ETHICS WHO ERC Guide for Principal InvestigatorsIntroduction

How to fill out continuing review form

How to fill out continuing review form

1. To fill out a continuing review form, follow these steps: 1. Access the form online or obtain a hard copy from the relevant regulatory body.
2. Fill in the top section of the form with your personal information, such as your name, contact information, and affiliation.
3. Provide the study title and protocol number, if applicable, in the designated fields.
4. Indicate the date of the previous review, as well as the date of the current review.
5. Describe any ongoing activities related to the study, including recruitment of subjects, data collection, or interventions.
6. Provide a summary of any adverse events or unexpected problems that have occurred since the previous review.
7. If there have been any modifications to the study protocol, specify the nature of the changes and their rationale.
8. Assess the risks and benefits of continuing the study, including any new information that may impact the balance of risks and benefits.
9. Consider whether any amendments should be made to the study procedures or informed consent process.
10. Finally, sign and date the form, and submit it to the appropriate review board or committee.

Who needs continuing review form?

1. Researchers or investigators who are conducting studies involving human subjects usually need to fill out a continuing review form.
2. Institutional review boards (IRBs) or ethics committees may require researchers to submit a continuing review form to ensure that ongoing studies comply with ethical guidelines and regulations.
3. Sponsors or funding agencies may also request a continuing review form as part of their monitoring or oversight processes.
4. Thus, anyone involved in human subjects research, particularly those conducting long-term or multi-phase studies, will likely need to complete a continuing review form.

For pdfFiller’s FAQs

How do I edit continuing review form online?

pdfFiller not only allows you to edit the content of your files but fully rearrange them by changing the number and sequence of pages. Upload your continuing review form to the editor and make any required adjustments in a couple of clicks. The editor enables you to blackout, type, and erase text in PDFs, add images, sticky notes and text boxes, and much more.

Can I sign the continuing review form electronically in Chrome?

Yes. With pdfFiller for Chrome, you can eSign documents and utilize the PDF editor all in one spot. Create a legally enforceable eSignature by sketching, typing, or uploading a handwritten signature image. You may eSign your continuing review form in seconds.

Can I edit continuing review form on an iOS device?

Use the pdfFiller mobile app to create, edit, and share continuing review form from your iOS device. Install it from the Apple Store in seconds. You can benefit from a free trial and choose a subscription that suits your needs.

What is continuing review form?

Continuing review form is a form used in research studies to ensure that the study continues to meet ethical and regulatory requirements.

Who is required to file continuing review form?

Researchers conducting studies that involve human subjects are required to file continuing review forms.

How to fill out continuing review form?

Continuing review forms should be filled out by providing updated information about the study protocol, any adverse events, and any changes to the study design.

What is the purpose of continuing review form?

The purpose of the continuing review form is to ensure that research studies involving human subjects are being conducted ethically and in compliance with regulations.

What information must be reported on continuing review form?

Information that must be reported on the continuing review form includes updated study protocol, any adverse events, changes to study design, and any new information that may impact the study.